Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 37.00 | |
2 mg | In stock | $ 50.00 | |
5 mg | In stock | $ 77.00 | |
10 mg | In stock | $ 115.00 | |
25 mg | In stock | $ 197.00 | |
50 mg | In stock | $ 295.00 | |
100 mg | In stock | $ 443.00 | |
200 mg | In stock | $ 653.00 | |
500 mg | In stock | $ 987.00 |
Description | Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others |
Molecular Weight | 322.27 |
Formula | C11H18N2O9 |
CAS No. | 3148-72-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Slightly soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
diaminohydroxypropanetetraacetic acid 3148-72-9 Others inhibitor inhibit